Macquarie Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Macquarie Group’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,363	Closed	-$8K	–	2159
2018 Q4	$8K	Sell	3,363 -5,679	-63%	-$33.3K	﹤0.01%	1974
2018 Q3	$66K	Sell	9,042 -5,716	-39%	-$25K	﹤0.01%	1675
2018 Q2	$55K	Buy	14,758 +4,700	+47%	+$21.7K	﹤0.01%	1938
2018 Q1	$39K	Sell	10,058 -1,200	-11%	-$5.04K	﹤0.01%	2019
2017 Q4	$41K	Buy	11,258 +3,677	+49%	+$13.9K	﹤0.01%	2023
2017 Q3	$30K	Buy	+7,581	New	+$34.8K	﹤0.01%	2060

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Macquarie Group's AGTC Position: Q1 2019 in Review

Macquarie Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2019, closing a stake of 3,363 shares — an estimated $8K sold.

Macquarie Group first reported a position in AGTC in Q3 2017 and held it in 6 quarters. The position peaked at $66K in Q3 2018. 50 funds tracked by Wall St. Rank hold AGTC as of Q1 2019.

Macquarie Group reported no remaining Applied Genetic Technologies Corporation position as of Q1 2019 after selling out during the quarter.
Macquarie Group sold 3,363 Applied Genetic Technologies Corporation shares in Q1 2019, an estimated $8K.
Macquarie Group first reported a position in Applied Genetic Technologies Corporation in Q3 2017 and held it in 6 quarters.
Macquarie Group's Applied Genetic Technologies Corporation position peaked at $66K in Q3 2018.
50 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.